Ocrelizumab modifies circulating immune asset in relapsing-remitting multiple sclerosis subjects

被引：0

作者：

Abbadessa, Gianmarco ^{[1
]}

Bruzzaniti, Sara ^{[2
]}

Miele, Giuseppina ^{[1
]}

Piemonte, Erica ^{[3
]}

Signoriello, Elisabetta ^{[1
]}

Lus, Giacomo ^{[1
]}

Matarese, Giuseppe ^{[3
]}

Galgani, Mario ^{[3
]}

Bonavita, Simona ^{[1
]}

机构：

[1] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Clin Neurol 2, Naples, Italy

[2] Univ Naples Federico II, Dipartimento Biol, Naples, Italy

[3] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2021年 / 429卷

关键词：

D O I：

10.1016/j.jns.2021.118820

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

118820

引用

页码：21 / 21

页数：1

共 50 条

[21] Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis (vol 15, 1480676, 2024) [J].

Rodriguez-Jorge, Fernando ;

Fernandez-Velasco, Jose Ignacio ;

Villarrubia, Noelia ;

Gracia-Gil, Julia ;

Fernandez, Eva ;

Meca-Lallana, Virginia ;

Diaz-Perez, Carolina ;

de la Maza, Susana Sainz ;

Pacheco, Eva Maria ;

Quiroga, Ana ;

Ramio-Torrenta, Lluis ;

Martinez-Yelamos, Sergio ;

Bau, Laura ;

Monreal, Enric ;

Lopez-Real, Ana ;

Rodero-Romero, Alexander ;

Borrega, Laura ;

Diaz, Santiago ;

Eguia, Pablo ;

Espino, Mercedes ;

Chico-Garcia, Juan Luis ;

Barrero, Francisco Javier ;

Martinez-Gines, Maria Luisa ;

Garcia-Dominguez, Jose Manuel ;

de la Fuente, Soraya ;

Moreno, Irene ;

Sainz-Amo, Raquel ;

Mane-Martinez, M. Alba ;

Caminero, Ana ;

Castellanos-Pinedo, Fernando ;

Lopez, Ana Gomez ;

Labiano-Fontcuberta, Andres ;

Ayuso, Lucia ;

Abreu, Rossana ;

Hernandez, Miguel angel ;

Meca-Lallana, Jose ;

Martin-Aguilar, Lorena ;

Garcia, Alfonso Muriel ;

Masjuan, Jaime ;

Costa-Frossard, Lucienne ;

Villar, Luisa Maria .

FRONTIERS IN IMMUNOLOGY, 2024, 15

[22] Depression in relapsing-remitting multiple sclerosis [J].

Mendes, MF ;

Tilbery, CP ;

Balsimelli, S ;

Moreira, MA ;

Barao-Cruz, AM .

ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (3A) :591-595

[23] Autohemotherapy for relapsing-remitting multiple sclerosis [J].

Mubaidin, AF ;

Horani, KA ;

Dehayyat, MA ;

Shehab, M ;

Abu-Ruman, IA ;

Shurbaji, AA ;

Kurdi, A ;

Hiari, M ;

Khakish, M ;

Harahsheh, O ;

Dabbas, M .

NEUROLOGY, 2001, 56 (08) :A75-A75

[24] Relapsing-remitting tumefactive multiple sclerosis [J].

Selkirk, SM ;

Shi, J .

MULTIPLE SCLEROSIS, 2005, 11 (06) :731-734

[25] Rituximab for relapsing-remitting multiple sclerosis [J].

He, Dian ;

Guo, Rui ;

Zhang, Fubo ;

Zhang, Chao ;

Dong, Shuai ;

Zhou, Hongyu .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12)

[26] Rapid Onset of Ocrelizumab Suppression of Brain MRI Activity in Relapsing-Remitting Multiple Sclerosis [J].

Barkhof, Frederik ;

Kappos, Ludwig ;

Bar-Or, Amit ;

Li, David ;

Belachew, Shibeshih ;

Julian, Laura ;

Sauter, Annette ;

Stokmaier, Daniela ;

Hauser, Stephen .

NEUROLOGY, 2017, 88

[27] Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis [J].

Escribano, Begona M. ;

Aguilar-Luque, Macarena ;

Bahamonde, Carmen ;

Conde, Cristina ;

Lillo, Rafael ;

Sanchez-Lopez, Fernando ;

Giraldo, Ana I. ;

Cruz, Antonio H. ;

Luque, Evelio ;

Gascon, Felix ;

Aguera, Eduardo ;

Tunez, Isaac .

CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (31) :4876-4880

[28] A non-inferiority study of rituximab versus ocrelizumab in relapsing-remitting multiple sclerosis [J].

Roos, I. ;

Hughes, S. ;

MacDonnell, G. ;

Boz, C. ;

Alroughani, R. ;

Ozakbas, S. ;

Buzzard, K. ;

Skibina, O. ;

Van der Walt, A. ;

Butzkueven, H. ;

Lechner-Scott, J. ;

Kuhle, J. ;

Terzi, M. ;

Laureys, G. ;

Van Hijfte, L. ;

John, N. ;

Grammond, P. ;

Grand'Maison, F. ;

Soysal, A. ;

Sellebjerg, F. ;

Gray, O. ;

Magyari, M. ;

Kalincik, T. ;

Msbase and Danish Sclerosis Registry Study Grp .

MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) :951-953

[29] Progressive multifocal encephalopathy in the first patient with relapsing-remitting multiple sclerosis treated with ocrelizumab [J].

Puig Casadevall, M. ;

Alvarez Bravo, G. ;

Coll-Martinez, C. ;

Quiroga-Varela, A. ;

Robles-Cedeno, R. ;

Gonzalez del Rio, M. ;

Salavedra-Pont, J. ;

Miguela, A. ;

Gich, J. ;

Ramio-Torrenta, L. ;

Boix-Lago, A. ;

Laguillo-Sala, G. .

MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) :679-680

[30] Ocrelizumab as first-line therapy in highly active relapsing-remitting multiple sclerosis [J].

Kvartskhava, Tamar ;

Freudenstein, David ;

Sarmiento, Nicolas ;

Angstwurm, Klemens ;

Linker, Ralf ;

Lee, De-Hyung .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2025, 475

← 1 2 3 4 5 →